National Health and Health Commission: Focus on promoting mature conditions in areas for free HPV vaccines

The National Health and Health Commission recently stated that it will vigorously promote the experience of Guangdong, Hainan, Fujian and other provinces, summarize the experience and practices of various channels such as government livelihood projects and medical insurance funds in various places, encourage localities to try first, and focus on promoting regions with mature conditions to introduce the first introduction Free HPV vaccination policies and continuously increase the HPV vaccination rate of girls with a suitable age.

According to the National Health and Health Commission, at present, my country's HPV vaccine has not been included in the national immunization plan, and inoculates in accordance with the principles of voluntary at their own expense. The National Health and Health Commission actively promotes the place where conditions permitted the HPV vaccination into the local policy of benefiting the people. The provinces of Guangdong, Hainan, and Fujian have successively launched the province's free vaccination of domestic binary HPV vaccines for free to take over the province, and incorporated the provincial party committee and provincial government for private projects in 2022. In May 2021, the National Health and Health Commission launched the pilot work of the "Healthy City Construction Promoting the Innovation of the Healthy China Action" in 15 cities across the country to explore and eliminate measures to eliminate the comprehensive prevention and control of cervical cancer.

It is understood that there are 5 HPV vaccine products in my country approved to register, including 3 imported HPV vaccines and 2 domestic HPV vaccines. According to the national regular immune report data, from 2018 to 2020, the number of HPV vaccinations reported in various places was 3.417 million, 6.753 million, and 12.279 million doses.

Cervical cancer is a malignant tumor that seriously threatens women's health. Studies have shown that high -risk human papilloma virus is also directly correlated with the incidence of cervical cancer in HPV. In order to vaccinate the HPV vaccine for women's age, HPV vaccines can block the continuous infection of high -risk HPV and effectively reduce the incidence of cervical cancer and pre -cancer lesions, especially for women who have not been infected with HPV.

Sichuan Observation (Source: CCTV News)

- END -